| Total | Both high | Both low |  | |||
---|---|---|---|---|---|---|---|
 | No. |  | No. | % | No. | % | P |
No. of patients | 196 | Â | 85 | 43.4 | 111 | 56.6 | Â |
Age, years | |||||||
≤45 | 102 | 52.0 | 32 | 31.4 | 70 | 68.6 | 0.0004 |
>45 | 94 | 48.0 | 53 | 56.4 | 41 | 43.6 | Â |
Extrathyroidal extension | |||||||
Absent | 87 | 44.4 | 32 | 36.8 | 55 | 63.2 | 0.0956 |
Present | 109 | 55.6 | 53 | 48.6 | 56 | 51.4 | Â |
Stagea | |||||||
I | 100 | 54.3 | 35 | 35.0 | 65 | 65.0 | 0.0146 |
II | 11 | 6.0 | 3 | 27.3 | 8 | 72.7 | Â |
III | 19 | 10.3 | 13 | 68.4 | 6 | 31.6 | Â |
IV | 54 | 29.4 | 28 | 51.8 | 26 | 48.2 | Â |
p-AKTb | |||||||
91 | 50.0 | 51 | 56.0 | 40 | 44.0 | 0.0045 | |
Low (0–1) | 91 | 50.0 | 32 | 35.2 | 59 | 64.8 |  |
PIK3CA-IHCb | |||||||
High | 139 | 71.7 | 73 | 52.5 | 66 | 47.5 | <0.0001 |
Low | 55 | 28.3 | 12 | 21.8 | 43 | 78.2 | Â |
BCLXLb | |||||||
High | 50 | 25.6 | 30 | 60.0 | 20 | 40.0 | 0.0068 |
Low | 145 | 74.4 | 55 | 37.9 | 90 | 62.1 | Â |
XIAPb | |||||||
High | 70 | 36.1 | 40 | 57.1 | 30 | 42.9 | 0.0049 |
Low | 124 | 63.9 | 45 | 36.3 | 79 | 63.7 | Â |
HGF-1b | |||||||
High | 38 | 21.0 | 30 | 79.0 | 8 | 21.0 | <0.0001 |
Low | 143 | 79.0 | 49 | 34.3 | 94 | 65.7 | Â |
c5-Year disease-free survival | Â | Â | Â | 75.6 | Â | 65.2 | 0.9623 |